Z. Mark

1.9k total citations
9 papers, 816 citations indexed

About

Z. Mark is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Z. Mark has authored 9 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Z. Mark's work include Chromosomal and Genetic Variations (2 papers), Epigenetics and DNA Methylation (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Z. Mark is often cited by papers focused on Chromosomal and Genetic Variations (2 papers), Epigenetics and DNA Methylation (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Z. Mark collaborates with scholars based in United States, Hungary and China. Z. Mark's co-authors include Stephen T. Holgate, William W. Busse, David Bernstein, James Baker, Klaus F. Rabe, Deborah A. Meyers, Ildikó Horváth, Peter J. Barnes, Sally E. Wenzel and Jean Bousquet and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Z. Mark

9 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Z. Mark United States	7	378	333	253	225	112	9	816
Céline Crahay Belgium	10	278 0.7×	229 0.7×	187 0.7×	152 0.7×	200 1.8×	11	752
Alexander Gregorieff Canada	6	305 0.8×	89 0.3×	214 0.8×	179 0.8×	50 0.4×	6	602
Randi Stern United States	13	280 0.7×	83 0.2×	152 0.6×	72 0.3×	40 0.4×	16	717
Y Basaki Japan	8	169 0.4×	155 0.5×	156 0.6×	78 0.3×	54 0.5×	12	512
Satoshi Miike Japan	8	139 0.4×	196 0.6×	216 0.9×	60 0.3×	48 0.4×	9	542
Jonathan Hannay United States	13	431 1.1×	185 0.6×	37 0.1×	177 0.8×	100 0.9×	17	756
Michael Plotnick United States	14	234 0.6×	60 0.2×	204 0.8×	42 0.2×	202 1.8×	15	715
Stephanie L. Kelich United States	8	207 0.5×	69 0.2×	272 1.1×	23 0.1×	103 0.9×	10	561
Craig D. Milne Canada	10	168 0.4×	74 0.2×	238 0.9×	40 0.2×	62 0.6×	12	503
Srinivas Mamidi Germany	14	391 1.0×	71 0.2×	485 1.9×	50 0.2×	47 0.4×	21	868

Countries citing papers authored by Z. Mark

Since Specialization

Citations

This map shows the geographic impact of Z. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Mark more than expected).

Fields of papers citing papers by Z. Mark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Mark. The network helps show where Z. Mark may publish in the future.

Co-authorship network of co-authors of Z. Mark

This figure shows the co-authorship network connecting the top 25 collaborators of Z. Mark. A scholar is included among the top collaborators of Z. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Z. Mark. Z. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Wang, Yuyan, Z. Mark, David Clark, et al.. (2017). A piRNA-like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma. Molecular Therapy — Nucleic Acids. 6. 269–278. 43 indexed citations

Mei, Yuping, Yuyan Wang, Priti Kumari, et al.. (2015). A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells. Nature Communications. 6(1). 7316–7316. 85 indexed citations

Mark, Z., Ruxian Lin, José A. Carrillo, et al.. (2015). ∆ DNMT3B4-del Contributes to Aberrant DNA Methylation Patterns in Lung Tumorigenesis. EBioMedicine. 2(10). 1340–1350. 8 indexed citations

Quoix, Élisabeth, Lecia V. Sequist, John Nemunaitis, et al.. (2014). TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). O12–O12. 4 indexed citations

Zhao, Jun, Z. Mark, Hening Ren, et al.. (2013). Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy. Clinical Cancer Research. 19(13). 3567–3576. 48 indexed citations

Hong, Xia, Z. Mark, Jeffrey C. Gildersleeve, et al.. (2012). Sugar-Binding Proteins from Fish: Selection of High Affinity “Lambodies” That Recognize Biomedically Relevant Glycans. ACS Chemical Biology. 8(1). 152–160. 51 indexed citations

Soria, Jean‐Charles, Z. Mark, Petr Zatloukal, et al.. (2011). Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 29(33). 4442–4451. 205 indexed citations

Wenzel, Sally E., Peter J. Barnes, Eugene R. Bleecker, et al.. (2009). A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma. American Journal of Respiratory and Critical Care Medicine. 179(7). 549–558. 370 indexed citations

Mark, Z., et al.. (1981). Light- and Electron Microscopic Studies of the Liver in “Bronze Baby” Syndrome. Pathology - Research and Practice. 172(1-2). 196–204. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact